Skip to Content

M L23 (Lisinopril 5 mg)

Pill with imprint M L23 is Orange, Round and has been identified as Lisinopril 5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; heart attack; alport syndrome; coronary artery disease (and more), and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for M L23

Lisinopril 5 mg M L23
Lisinopril 5 mg M L23  Front
Lisinopril 5 mg M L23  Back
Lisinopril 5 mg M L23
Lisinopril 5 mg M L23

Lisinopril

Imprint:
M L23
Strength:
5 mg
Color:
Orange
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
povidone
corn starch
sodium lauryl sulfate
FD&C Yellow No. 6
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
51079-0981 UDL Laboratories Inc.
63874-0558 Altura Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide